XML 40 R28.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2015
Equity [Abstract]  
Summary of Stock Option Activity

The following table summarizes stock option activity for the nine months ended September 30, 2015:

 

     Number of
Options
     Weighted
Average
Exercise Price
     Weighted
Average
Remaining
Contractual Term
(in years)
     Aggregate Intrinsic
Value (1)
 

Outstanding at December 31, 2014

     10,135,914       $ 16.76         

Granted

     1,631,634       $ 53.86         

Exercised

     (1,278,016    $ 11.22         

Forfeited/expired

     (230,274    $ 41.34         
  

 

 

          

Outstanding at September 30, 2015

     10,259,258       $ 22.80         6.24       $ 221.5   
  

 

 

          

Vested and exercisable at September 30, 2015

     6,893,054       $ 13.05         5.02       $ 203.1   
  

 

 

          

 

(1)  The aggregate intrinsic value is calculated as the pre-tax difference between the weighted average exercise price of the underlying awards and the closing price per share of $42.50 of the Company’s common stock on September 30, 2015. The calculation excludes any awards with an exercise price higher than the closing price of the Company’s common stock on September 30, 2015. The amounts are presented in millions.
Summary of Restricted Stock Units

The following table summarizes restricted stock unit activity for the nine months ended September 30, 2015:

 

     Number of
Shares
     Weighted-
Average
Grant-Date
Fair Value
 

Unvested at December 31, 2014

     967,160       $ 38.10   

Granted

     574,695       $ 53.93   

Vested

     (247,572    $ 38.04   

Forfeited

     (98,926    $ 44.84   
  

 

 

    

Unvested at September 30, 2015

     1,195,357       $ 45.16   
  

 

 

    
Summary of Stock Appreciation Rights Activity

The following table summarizes stock appreciation rights activity for the nine months ended September 30, 2015:

 

     Number of
Rights
     Weighted
Average
Exercise Price
     Weighted
Average
Remaining
Contractual Term
(in years)
     Aggregate Intrinsic
Value (1)
 

Outstanding at December 31, 2014

     1,376,456       $ 12.03         

Granted

     —          —          

Exercised

     (55,048    $ 11.60         

Forfeited

     (17,156    $ 11.60         
  

 

 

          

Outstanding at September 30, 2015

     1,304,252       $ 12.05         6.19       $ 39.7   
  

 

 

          

Vested and exercisable at September 30, 2015

     1,213,404       $ 12.05         6.18       $ 36.9   
  

 

 

          

 

(1) The aggregate intrinsic value is calculated as the pre-tax difference between the weighted average exercise price of the underlying awards and the closing price per share of $42.50 of the Company’s common stock on September 30, 2015. The calculation excludes any awards with an exercise price higher than the closing price of the Company’s common stock on September 30, 2015. The amounts are presented in millions.
Schedule of Black-Scholes Assumptions Used for Stock Options
The Black-Scholes assumptions used to estimate the fair value of stock options granted were as follows:

 

     Three Months Ended
September 30,
  Nine Months Ended
September 30,
     2015   2014   2015   2014

Risk-free interest rate

   1.37-1.77%   1.56-1.79%   1.33-1.78%   1.56-1.79%

Estimated term (in years)

   5.01-7.17   5.06   4.99-7.17   5.06-5.50

Estimated volatility

   57-64%   63%   50-64%   60-64%

Estimated dividend yield

        
Schedule of Black-Scholes Assumptions Used to Estimate Fair Value of Shares Issued under ESPP

The Black-Scholes assumptions used to estimate the fair value of shares issued under the ESPP on the commencement date of the offering period were as follows:

 

     Nine Months Ended
September 30,
 
     2015     2014  

Risk-free interest rate

     0.12     0.06

Estimated term (in years)

     0.50        0.50   

Estimated volatility

     37     53

Estimated dividend yield

     —        
Schedule of Stock-Based Compensation Expense

Stock-based compensation expense was as follows:

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2015      2014      2015      2014  

Stock-based compensation expense recognized as:

           

R&D expense

   $ 5,673       $ 4,611       $ 17,593       $ 13,236   

SG&A expense

     7,719         7,346         23,249         19,563   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 13,392       $ 11,957       $ 40,842       $ 32,799